Cargando…
Adeno-associated virus-based caveolin-1 delivery via different routes for the prevention of cholesterol gallstone formation
BACKGROUND: Hepatic caveolin-1 (CAV1) is reduced in cholesterol gallstone disease (CGD). Mice with CAV1 deficiency were prone to develop CGD. However, it remains unknown whether restored hepatic CAV1 expression prevents the development of CGD. METHODS: C57BL/6 mice were injected with adeno-associate...
Autores principales: | Li, Sha, Chen, Hongtan, Jiang, Xin, Hu, Fengling, Li, Yiqiao, Xu, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609467/ https://www.ncbi.nlm.nih.gov/pubmed/36303150 http://dx.doi.org/10.1186/s12944-022-01718-7 |
Ejemplares similares
-
Effect of hepatic NPC1L1 on cholesterol gallstone disease and its mechanism
por: Mo, Pingfan, et al.
Publicado: (2023) -
FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice
por: Mo, Pingfan, et al.
Publicado: (2022) -
Osteopontin and integrin are involved in cholesterol gallstone formation
por: Yang, Lin, et al.
Publicado: (2012) -
Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet
por: Han, Tao, et al.
Publicado: (2019) -
Pathogenesis of Cholesterol Gallstones
por: Strasberg, Steven M., et al.
Publicado: (1991)